Recent Developments in HPLC Analysis of [beta]-Blockers in Biological Samples

[beta]-Adrenergic blockers represent a very important class of drugs that are used worldwide for treating various cardiac diseases. The present article describes the state-of-the art of analyses of [beta]-adrenergic blockers using high-performance liquid chromatography (HPLC). Sample preparation tec...

Full description

Saved in:
Bibliographic Details
Published in:Journal of chromatographic science Vol. 51; no. 8; pp. 807 - 818
Main Authors: Saleem, Kishwar, Ali, Imran, Kulsum, Umma, Aboul-Enein, Hassan Y
Format: Journal Article
Language:English
Published: 01-09-2013
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[beta]-Adrenergic blockers represent a very important class of drugs that are used worldwide for treating various cardiac diseases. The present article describes the state-of-the art of analyses of [beta]-adrenergic blockers using high-performance liquid chromatography (HPLC). Sample preparation techniques such as liquid-liquid extraction, solid-phase extraction and solid-phase microextraction have been discussed, which are essential prior to HPLC analysis. Additionally, applications of liquid chromatography coupled with tandem mass spectrometry are included. HPLC methods have been reported to include 0.6-26 min as the run times and 0.01 ng/mL to 25 [mu]g/mL as detection limits. The most commonly used columns were C sub(18) with various buffers as the mobile phases, along with various organic modifiers. The optimization of HPLC conditions has been discussed. It has been observed that the reported methods are quite satisfactory for the analyses of [beta]-adrenergic blockers in biological samples. Future perspectives in the hyphenation of solid-phase microextraction-nano-liquid chromatography-tandem mass spectrometry have also been highlighted to achieve detections at nanogram and picogram levels. The present article is very useful for academicians, scientists, drug and pharmaceutical personnel and government regulatory authorities.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Feature-2
ISSN:0021-9665
1945-239X
DOI:10.1093/chromsci/bmt030